Skip to main content
Previous
Poster Home
Next
Assessment of Sustained MRD Negativity and Reversion in Real-World Multiple Myeloma Patients Using NGS (clonoSEQ Assay)
07:30am - 03:45pm EST - April 1, 2023
Information
Resources
Play Recording
https://jnccn.org/view/journal...
Author(s):
Dr. Miao Jiang, PhD
, Director, Real World Evidence, Adaptive Biotechnologies Corporation
Tags:
Outcomes and Health Services Research
Display Label
Action
2023 NCCN Annual Meeting Poster_submitted.pdf
Download Handout
AC23P129 - Assessment of Sustained MRD Negativity and Reversion in Real-World Multiple Myeloma Patients Using NGS (clonoSEQ Assay)
Download MP3